Ortho Clinical Diagnostics Holdings plc Total Revenue

The latest total revenue for OCDX is $2B as of April 2022. That compares with $1.9B in the prior-year period — up 9.2% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Ortho Clinical Diagnostics Holdings plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, OCDX's total revenue moved from $1.9B to $2B — a 9.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ortho Clinical Diagnostics Holdings plc's operating scale or balance-sheet position.

Against Healthcare companies, OCDX currently prints $2B for total revenue, while the sector average sits near $110B. That is roughly 98.2% below the sector mean. Large gaps often invite a closer look at Ortho Clinical Diagnostics Holdings plc's growth, margins, and balance sheet.

A total revenue figure of $2B for OCDX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting OCDX's total revenue ($2B), review year-over-year change from $1.9B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.